Why Are Autism And Adhd Linked

Autism and ADHD are linked because they share genetic roots, overlapping brain wiring, and similar patterns of cognitive function. About one in three autistic children also meets the criteria for ADHD, and roughly 10% of children with ADHD meet the criteria for autism. These aren’t just conditions that happen to coexist by chance. They appear to grow from common biological soil, which is why so many people experience both.

They Share Genetic Pathways

Both conditions are highly heritable, and a significant portion of their genetic architecture overlaps. The chemical messenger systems most strongly implicated in ADHD, specifically dopamine and norepinephrine signaling, also show abnormal functioning in autism. Serotonin pathways are similarly disrupted in both conditions. Because the same neurotransmitter systems are involved, genes that regulate these pathways are prime candidates for influencing both diagnoses.

Some specific genetic findings illustrate the connection. A variation in the MAOA gene, which helps break down neurotransmitters in the brain, has been linked to the severity of ADHD symptoms in boys with autism, suggesting the two conditions share underlying biological mechanisms. In rarer cases, a mutation on the X chromosome’s FMR1 gene (the gene involved in Fragile X syndrome) can produce a combined autism-ADHD presentation. Duplications on a segment of chromosome 15 have also been identified as a cause of both conditions appearing together.

Their Brains Are Wired Similarly

Neuroimaging research reveals that autism and ADHD produce overlapping changes in brain connectivity. Both groups show reduced connectivity in the right amygdala, a region central to processing emotions, and the right parahippocampal gyrus, which is part of the default mode network and plays a role in memory. Both groups also share additional hub regions that differ from typical development, including areas involved in language processing, sensory input, and higher-level planning in the frontal lobe.

A large brain imaging study of over 1,300 participants between ages 7 and 21 confirmed that both conditions involve disrupted connectivity in three major brain networks: the default mode network (active during rest and internal thought), the dorsal attention network (which directs focus to external tasks), and the salience network (which helps the brain decide what deserves attention). These are the same networks that govern attention, social cognition, and self-regulation, which explains why both conditions produce difficulties in those areas despite looking different on the surface.

The Symptoms Overlap More Than You’d Expect

Autism and ADHD are defined by different diagnostic criteria, but in practice, many symptoms bleed across the boundary. Attention difficulties are common in autistic people even when ADHD isn’t formally diagnosed. Social skill deficits, peer relationship problems, and difficulty reading social cues, all hallmarks of autism, appear at elevated rates in children with ADHD. Research has found that children with ADHD show elevated ratings of core autistic traits that can’t be explained by ADHD or behavioral problems alone.

This overlap made the conditions hard to study for decades. Before 2013, the DSM (the manual clinicians use to diagnose mental health conditions) explicitly prohibited giving someone both diagnoses. If a child had autism, ADHD was ruled out by definition. The DSM-5 changed that, recognizing for the first time that the two conditions co-occur frequently enough to warrant a dual diagnosis. That single rule change opened the door to much of the research we now have.

Executive Function Deficits Are Nearly Identical

Executive functions are the cognitive skills you rely on to plan, organize, control impulses, hold information in working memory, and shift flexibly between tasks. Both autism and ADHD produce significant impairments across nearly all of these domains. Recent meta-analyses have found no meaningful differences in executive function profiles between children with ADHD and children with autism, which is striking given how different the two conditions appear behaviorally.

In direct comparisons against typically developing children, both groups show significant deficits in impulse control, mental flexibility (the ability to shift between tasks or ideas), emotional regulation, planning, organization, and self-monitoring. Working memory deficits appear in both groups, though they tend to be somewhat more pronounced in ADHD. Some researchers argue that these shared executive function deficits are the strongest evidence that autism and ADHD share overlapping neural mechanisms rather than simply co-occurring by coincidence.

Sensory Processing Differences Connect Them

Atypical sensory processing is a core diagnostic feature of autism, but it’s also increasingly recognized in ADHD. Children with both conditions process sensory input differently from their peers: they may be hypersensitive to certain textures, sounds, or lights, or they may under-register sensory input and seek out extra stimulation. In ADHD, these sensory differences are correlated with inattention and working memory problems. In autism, they track with the severity of core social and cognitive features.

When both conditions are present together, sensory issues tend to be more pronounced. Children with combined autism and ADHD show heightened emotional problems that appear to be driven, at least in part, by more severe atypical sensory processing. This suggests that the sensory differences aren’t just a side effect of either condition but a shared feature that compounds when both are present.

What This Means for Treatment

The biological overlap between autism and ADHD has practical consequences for treatment. Standard ADHD medications, particularly methylphenidate (the active ingredient in Ritalin and Concerta), do work for autistic people with ADHD symptoms, showing small to large improvements in hyperactivity and inattention. It remains the first-line medication option for ADHD symptoms in autistic individuals. Non-stimulant options like atomoxetine and guanfacine also show emerging evidence of reducing ADHD symptoms in this group.

However, the shared biology also means that treatment is rarely straightforward. Medications that improve attention through norepinephrine signaling can have beneficial effects for focus and impulse control, but their impact on core autism-related features like social communication or restricted interests is less clear. Because the two conditions interact at the level of brain networks, sensory processing, and executive function, managing one without considering the other often leaves significant challenges unaddressed. The growing recognition of their shared roots is pushing clinicians toward more integrated approaches that treat the overlapping profile rather than each diagnosis in isolation.